---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018313"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:51:04.590137+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio appoints Emil Chuang to board; Fischbein resigns

## Summary
- Margery Fischbein resigned from board effective July 2, 2025; no disagreement with company.
- Board accelerated vesting of Fischbein's 3,100 outstanding stock options to fully vested.
- Emil Chuang, MB BS FRACP, appointed to board effective July 7, 2025; also joins audit, compensation, governance committees.
- Chuang is a pediatric gastroenterologist with nearly 25 yrs experience, contributed to two NDA/sBLA approvals.
- Chuang granted non-statutory stock option to purchase 8,000 shares at closing price on grant date.

## SEC filing metadata
- accession: 0001641172-25-018313
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/0001641172-25-018313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018313
- JSON: https://secwatch.observer/filing/0001641172-25-018313.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018313.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.